2022 Kidney and Pancreas Transplant Virtual CME Series: Penn Transplant Institute

The Penn Transplant Institute has returned to the educational forum with its renowned series of virtual CME events.

This year's series featured three considerations of kidney transplantation, with a review of living donor kidney transplantation, an examination of the recent changes to UNOS kidney allocation policy, and a presentation on pancreas transplantation as an option for insulin dependent diabetics with chronic kidney disease facing the need for kidney transplantation.

The series webinars were conveniently planned for the evening hours, open to nephrologists and all healthcare providers treating patients with chronic kidney disease.

Session recordings were released on YouTube following the event and you can view them below. Please note that CME credit is no longer available for this series. Consider registering for the Penn Kidney Transplant Symposium on Tuesday, September 13, 2022.

Living Donor Kidney Transplantation

Session Recording

Faculty

• Amanda Leonberg-Yoo, MD,
  Medical Director, Living Donor Kidney Transplant Program

Medical Director Amanda Leonberg-Yoo, MD, of the Penn Transplant Institute's Living Donor Kidney Transplant Program presented session one to review living donor kidney transplantation, the most effective modality of renal replacement therapy for patients with irreversible chronic kidney failure.

This session highlights the evidence suggesting that patients receive the best outcomes when they receive a living donor kidney transplant early in the course of renal replacement therapy as well as innovations in paired kidney exchange that represent exciting clinical opportunities including increasing transplantation rates. The living donor transplant surgery was also reviewed.

You can view the session recording above. Please note that CME credit is no longer available for session one of the series. We look forward to seeing you at the remaining sessions. 

Pancreas Transplantation: Changes in Eligibility and Improving Outcomes

Session Recording

Faculty

• Ty Dunn, MD,
  Surgical Director, Kidney and Pancreas Transplant Programs

Surgical Director Ty Dunn, MD, of the Penn Transplant Institute's Kidney and Pancreas Transplant Programs presented session two to discuss pancreas transplantation, the most impactful treatment option for insulin dependent diabetics with chronic kidney disease facing the need for kidney transplantation.

This session highlights how outcomes of pancreas transplantation have improved over the past two decades secondary to advancements in surgical technique and immunosuppression management, as well as due to improved donor and recipient selection. 

Kidney Allocation Update: Understanding Patient Impact & Preliminary Outcomes

Preliminary outcomes of the new UNOS kidney allocation policy will be reviewed as well as unintended outcomes that are impacting patients in the greater Philadelphia region. The evolution of the allocation policies will be discussed. Effective strategies to decrease waiting time will be highlighted.

Session Recording

Faculty

• Roy Bloom, MD
  Medical Director, Kidney and Pancreas Transplant Programs

Roy Bloom, MD, Medical Director of the Penn Transplant Institute's Kidney and Pancreas Transplant Programs, presents session three of this year's Kidney and Pancreas Transplant Virtual CME Series to discuss preliminary outcomes of the new UNOS kidney allocation policy as well as unintended outcomes that are impacting patients in the greater Philadelphia region. Also discussed are the evolution of the allocation policies and effective strategies to decrease waiting time.

This session reviews the evolution of allocation by geography, the effects of allocation changes to kidney transplant wait times, and optimization of referral and transplant processes.